Atlas Trials

Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus

Clinical trial NCT06356740 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06356740
Sponsor
Hospices Civils de Lyon
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2024-09-01
Primary completion
2028-11-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.